In a historic milestone for medicine, patients with sickle cell disease are being cured through CRISPR gene editing therapy. Casgevy, approved by the FDA in late 2023, has now treated hundreds of patients with remarkable success.
Victoria Gray, the first American to receive the treatment, recently celebrated five years without a sickle cell crisis — something unimaginable before. "I feel like a new person," she said. "I can do things I never could before."
“Casgevy, approved by the FDA in late 2023, has now treated hundreds of patients with remarkable success.”
The therapy works by editing patients' own stem cells to produce fetal hemoglobin, which prevents the sickling of red blood cells. While expensive, the one-time treatment offers a permanent cure for a disease that affects millions worldwide.
How did this story make you feel?
📎 Cite this article
Good News Good Vibes. (2024, December 8). First CRISPR Gene Therapy Cures Sickle Cell Disease Patients. Retrieved from https://goodnewsgoodvibes.com/en/article/crispr-sickle-cell-cure-approved-2024
https://goodnewsgoodvibes.com/en/article/crispr-sickle-cell-cure-approved-2024
Editorial Team
Our editorial team curates and verifies positive news from credible sources worldwide.
Last reviewed: March 21, 2026
Trending
A Tiny Device Brings Quantum Entanglement to Room Temperature
Science · 5 min
A Louisville Restaurant Gives Away 100% of Its Profits — and Topped $100,000 in Year One
Community · 4 min
Oregon Zoo Sets a Record With 15 California Condor Chicks in One Year
Animals · 5 min
Europe Tears Down a Record 603 River Barriers, Setting Its Waters Free
Environment · 5 min
DeepMind unveils Co-Scientist, an AI research partner that already helped find a liver-disease drug candidate
Artificial Intelligence · 5 min
